Stay in touch with NCATS by connecting via social media, joining our listserv for frequent announcements, and subscribing to our monthly e-newsletter.
Explore the full spectrum of translational science, including NCATS' role in transforming knowledge into treatments.
Review a list of all the innovative programs and initiatives that NCATS supports.
CTSA Program hub (funded by NCATS) at UF helps physician pursue research project in sepsis patients.
All CTSA Program sites have signed on to the SMART IRB agreement, which will enable all participating study sites to rely on one IRB for each study.
Patient-focused collaboration among government and academic scientists enabled the advance of a potential treatment for the rare disease Niemann-Pick type C1.
NCATS seeks stem cell research collaborators from the biotechnology, pharmaceutical, and NIH intramural and extramural communities.
Read about NCATS’ collaborative work to streamline multisite clinical studies, develop a new candidate drug treatment for NPC1, and more.
Opportunities to repurpose drugs through public-private partnerships.
Two new chapters added to the best practices guide.
Christopher P. Austin, M.D.
Watch rare disease patients and caregivers talk about the challenges they face and how NIH’s collaborative research efforts offer hope. View the videos.
Learn more about all the ways that potential grantees, partners and collaborators can access NCATS support to advance translational science.
More News & Events …